Abstract
Objective Previous studies discussing the association between sleep duration and the prevalence of metabolic syndrome have reported different results, most of which targeted at adults. We are devoted to investigating the effects of sleep time for metabolic syndrome in children conducting a meta-analysis.
Methods Several cross-sectional studies were retrieved from Pubmed, Ovid, Cochrane, and Embase from inception to October 2021. Fixed-effect models and random-effect models were used to analyze the effects of sleep time on metabolic syndrome in adolescents based on the research above.
Results We collected data from 10 cross-sectional studies including 15877 children. Using random-effect models, compared with normal sleep time, we found out that both relatively short (OR = 0.81, 95%CI = 0.55-1.07, I-squared = 45.6%, p = 0.075) and long (OR = 0.86, 95%CI = 0.54-1.19, I-squared = 67.8%, p = 0.003) sleep durations were not associated with high prevalence of metabolic syndrome in adolescents and children. Using fixed-effect model on short sleep duration and it turned out to be statistically significant (OR = 0.76, 95%CI = 0.59-0.93).
Conclusions Long sleep duration made no significant difference in the risk of metabolic syndrome in adolescents and children, while short sleep duration seems to be a protective factor. Further studies are required to establish whether the association is causal and modifiable.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
https://pubmed.ncbi.nlm.nih.gov/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
